231 related articles for article (PubMed ID: 11012437)
1. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging.
Ichikawa T; Federle MP; Grazioli L; Marsh W
Radiology; 2000 Oct; 217(1):145-51. PubMed ID: 11012437
[TBL] [Abstract][Full Text] [Related]
2. Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management.
Stevens WR; Johnson CD; Stephens DH; Nagorney DM
AJR Am J Roentgenol; 1995 May; 164(5):1153-8. PubMed ID: 7717223
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
[TBL] [Abstract][Full Text] [Related]
4. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases.
Ichikawa T; Federle MP; Grazioli L; Madariaga J; Nalesnik M; Marsh W
Radiology; 1999 Nov; 213(2):352-61. PubMed ID: 10551212
[TBL] [Abstract][Full Text] [Related]
5. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
6. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation.
Hunt SJ; Yu W; Weintraub J; Prince MR; Kothary N
J Vasc Interv Radiol; 2009 Jan; 20(1):30-8. PubMed ID: 19028117
[TBL] [Abstract][Full Text] [Related]
7. Imaging of fibrolamellar hepatocellular carcinoma.
Brandt DJ; Johnson CD; Stephens DH; Weiland LH
AJR Am J Roentgenol; 1988 Aug; 151(2):295-9. PubMed ID: 2839968
[TBL] [Abstract][Full Text] [Related]
8. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases.
Jung SM; Jang JW; You CR; Yoo SH; Kwon JH; Bae SH; Choi JY; Yoon SK; Chung KW; Kay CS; Jung HS
J Gastroenterol Hepatol; 2012 Apr; 27(4):684-9. PubMed ID: 21916984
[TBL] [Abstract][Full Text] [Related]
9. Extension of surgical indication for advanced hepatocellular carcinoma: is it possible to prolong life span or improve quality of life?
Tanaka A; Morimoto T; Ozaki N; Ikai I; Yamamoto Y; Tsunekawa S; Kitai T; Yamaoka Y
Hepatogastroenterology; 1996; 43(11):1172-81. PubMed ID: 8908547
[TBL] [Abstract][Full Text] [Related]
10. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.
Chopra S; Dodd GD; Chintapalli KN; Leyendecker JR; Karahan OI; Rhim H
AJR Am J Roentgenol; 2001 Aug; 177(2):381-7. PubMed ID: 11461868
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
[TBL] [Abstract][Full Text] [Related]
12. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced mr imaging versus combined helical CT during arterial portography and CT hepatic arteriography.
Choi D; Kim S; Lim J; Lee W; Jang H; Lee S; Lim H
AJR Am J Roentgenol; 2001 Feb; 176(2):475-82. PubMed ID: 11159099
[TBL] [Abstract][Full Text] [Related]
13. Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria.
Blachar A; Federle MP; Ferris JV; Lacomis JM; Waltz JS; Armfield DR; Chu G; Almusa O; Grazioli L; Balzano E; Li W
Radiology; 2002 May; 223(2):532-9. PubMed ID: 11997564
[TBL] [Abstract][Full Text] [Related]
14. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection.
Kim SH; Lim HK; Lee WJ; Choi D; Park CK
Eur J Radiol; 2009 Jan; 69(1):123-30. PubMed ID: 17976942
[TBL] [Abstract][Full Text] [Related]
15. Extrahepatic metastases of hepatocellular carcinoma.
Katyal S; Oliver JH; Peterson MS; Ferris JV; Carr BS; Baron RL
Radiology; 2000 Sep; 216(3):698-703. PubMed ID: 10966697
[TBL] [Abstract][Full Text] [Related]
16. Fibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases.
Ganeshan D; Szklaruk J; Kaseb A; Kattan A; Elsayes KM
Abdom Radiol (NY); 2018 Dec; 43(12):3340-3348. PubMed ID: 29948061
[TBL] [Abstract][Full Text] [Related]
17. Outcome of patients with fibrolamellar hepatocellular carcinoma.
Stipa F; Yoon SS; Liau KH; Fong Y; Jarnagin WR; D'Angelica M; Abou-Alfa G; Blumgart LH; DeMatteo RP
Cancer; 2006 Mar; 106(6):1331-8. PubMed ID: 16475212
[TBL] [Abstract][Full Text] [Related]
18. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents.
Brancatelli G; Federle MP; Grazioli L; Carr BI
Radiology; 2002 Jan; 222(1):89-94. PubMed ID: 11756710
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
